Are patients still talking about Covid-19?

As the COVID pandemic unfolded, pharmaceutical companies were suddenly thrust into the limelight with the virus becoming a household topic. Fast forward three and a half years, these very same companies are now rolling out their updated mRNA Covid-19 vaccines to combat the prevalent circulating variants [1].

In March 2020, numerous states implemented stay-at-home orders, causing millions to turn to the internet for communication. This situation led to a staggering 5-fold surge in online conversations about vaccines compared to pre-pandemic times. Now, nearly 4 years after the pandemic began, is the patient still talking about COVID?Talking Medicines is revolutionizing healthcare by unlocking intelligence within Conversational Data.  

A sample of Conversational Data from over 8,000 unique sources (sourced from Talking Medicines’ Data Aggregator) was curated. The examination focused on aggregated trends and patterns within the evolving discourse surrounding Covid-19 vaccine brands, since the onset of the pandemic. The data was classified using Talking Medicines’ proprietary patient voice classifier and encompassed both conventional medical platforms and other open sites where authors share their health experiences. 

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. The Talking Medicines mission is to be the World’s Gold Standard for Patient Intelligence by Medicine.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Tern plc

More articles like this

Tern plc

Understanding Identity Access Management solutions

Identity Access Management (IAM) solutions play a critical role in minimising cyber and data governance risks by tracking and restricting access to digital systems. Fundamentally, IAM solutions capture and log user login information, manage the database

Tern plc

Device Authority welcomes new VP of Customer Success

Device Authority, a recognised global leader in Identity and Access Management (IAM) for Enterprise IoT ecosystems, has announced the addition of Steve Huehmer, an experienced Customer Success expert, to their team. Steve Huehmer, based in Boston,

Revolutionising global IoT connectivity

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. Wyld Networks is uniquely placed to deliver fixed and mobile mesh technology

Tern plc

Tern’s FY23 results show promising metrics and strategic growth

Tern’s FY23 results showcase improving metrics that are likely to attract additional strategic interest across its portfolio. All companies within Tern’s portfolio are experiencing significant commercial traction. Configuration work is transitioning to repeat licencing through SaaS

Tern plc

Pioneering solutions for obesity and type 2 diabetes

As the quest for the ultimate solution to type 2 diabetes heats up, GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) agonists have emerged as game-changing treatments, revolutionising the management of type 2 diabetes and obesity.

Tern plc

The impact of data-driven healthcare on patient care

Empirical evidence has long driven healthcare innovation, but the rapid deployment of digital solutions is generating vast quantities of data, offering new opportunities for data-driven patient care. Digital healthcare encompasses various technologies, including mobile health apps,

Tern plc

Accelerating IoT adoption

The excitement surrounding the Internet of Things (IoT) has driven significant growth in its adoption, with connected devices rising from 8.6 billion in 2019 to 15.4 billion by 2023, and projections of nearly 30 billion by

Tern plc

NIS 2 Directive in the European Union

In today’s interconnected world, the Internet of Things (IoT) plays a crucial role in various sectors, from healthcare and transportation to energy and critical infrastructure. However, with the increasing reliance on IoT devices comes the heightened

Tern plc

Healthcare marketing with AI: Drug-GPT and Audience Analyzer

The evolution of healthcare marketing is being rewritten by the innovative use of Artificial Intelligence (AI), particularly with solutions like Drug-GPT at the forefront. Today’s healthcare Strategists face the complex challenge of interpreting an ever-growing chorus